Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 8, 2008 - Issue 12
Submit an article Journal homepage
171
Views
21
CrossRef citations to date
0
Altmetric
Reviews

FOXP3+ regulatory T cells as biomarkers in human malignancies

Paola A Bignone University of Oxford, John Radcliffe Hospital, Level 4 Academic Block, Nuffield Department of Clinical Laboratory Sciences, Headington, Oxfordshire, OX3 9DU, UK +44 0 1865 220246; +44 0 1865 228980; [email protected]
&
Alison H Banham University of Oxford, John Radcliffe Hospital, Level 4 Academic Block, Nuffield Department of Clinical Laboratory Sciences, Headington, Oxfordshire, OX3 9DU, UK +44 0 1865 220246; +44 0 1865 228980; [email protected]
Pages 1897-1920 | Published online: 06 Nov 2008
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Abstract

Background: Regulatory T cells (Treg) expressing the FOXP3 forkhead transcription factor maintain immunological self-tolerance and can enable tumour cells to escape immunosurveillance. Objective: To provide an overview of studies using FOXP3 as a biomarker in human malignancies, particularly in the context of the antibodies used to detect FOXP3 protein expression, the cell populations selected for study, and the detection and scoring methodologies used. Methods: A personal selection of studies analysing FOXP3 as a marker of Treg cells in human malignancies are discussed. Results/conclusion: FOXP3 is a useful marker that can be used in routine clinical practise to provide both diagnostic and prognostic information in human malignancies. However, the methods and reagents used to detect FOXP3 can have a significant effect on the robustness of experimental findings and conclusions.

Acknowledgments

Our research is supported by funding from the Leukaemia Research Fund and Cancer Research UK.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related Research Data

Cutting edge: human CD4-CD8- thymocytes express FOXP3 in the absence of a TCR.
Source: The American Association of Immunologists
High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma.
Source: American Society of Hematology
The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs
Source: American Society for Clinical Investigation
SMART, a simple modular architecture research tool: Identification of signaling domains
Source: Proceedings of the National Academy of Sciences
FOXP3+ Tregs and B7-H1+/PD-1+ T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapy.
Source: BMC
Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4 + CD25 – T cells
Source: American Society for Clinical Investigation
Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes
Source: American Society of Hematology
Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer.
Source: American Association for Cancer Research (AACR)
Is FOXP3 a bona fide marker for human regulatory T cells
Source: Wiley
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
Source: Proceedings of the National Academy of Sciences
Regulatory T cells and tumour immunity
Source: Wiley
Cutting Edge: Direct Suppression of B Cells by CD4+CD25+ Regulatory T Cells
Source: The American Association of Immunologists
Phase- and stage-related proportions of T cells bearing the transcription factor FOXP3 infiltrate primary melanoma
Source: Elsevier BV
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Source: Rockefeller University Press
Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level.
Source: Wiley
Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4+CD25– cells
Source: Wiley
Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival
Source: Springer Science and Business Media LLC
Prevalence of FOXP3+ Regulatory T Cells Increases During the Progression of Pancreatic Ductal Adenocarcinoma and Its Premalignant Lesions
Source: American Association for Cancer Research (AACR)
Regulatory T-cell phenotype in association with large cell transformation of mycosis fungoides.
Source: Wiley
FOXP3 in CD30 positive lymphomas
Source: Wiley
FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival
Source: Springer Science and Business Media LLC
The presence of tumor-infiltrating FOXP3+ lymphocytes correlates with intratumoral angiogenesis in endometrial cancer
Source: Elsevier BV
Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia
Source: American Society of Hematology
Immunoregulatory T cells: role and potential as a target in malignancy.
Source: Springer Science and Business Media LLC
Essential roles of CD8+CD122+ regulatory T cells in the maintenance of T cell homeostasis.
Source: Rockefeller University Press
Regulatory T cells and treatment of cancer
Source: Elsevier BV
Enhanced Functionality of CD4+CD25highFoxP3+ Regulatory T Cells in the Peripheral Blood of Patients with Prostate Cancer
Source: American Association for Cancer Research (AACR)
The Scurfy mutation of FoxP3 in the thymus stroma leads to defective thymopoiesis
Source: The University of North Carolina at Chapel Hill University Libraries
Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating foxp3+ regulatory T cells.
Source: American Association for Cancer Research (AACR)
Increase in circulating Foxp3+CD4+CD25(high) regulatory T cells in nasopharyngeal carcinoma patients
Source: Springer Science and Business Media LLC
Impact of tumor-infiltrating T cells on survival in patients with malignant pleural mesothelioma
Source: Elsevier BV
Nucleophosmin/anaplastic lymphoma kinase (NPM/ALK) oncoprotein induces the T regulatory cell phenotype by activating STAT3
Source: Proceedings of the National Academy of Sciences
Analysis of FOXP3 protein expression in human CD4(+)CD25(+) regulatory T cells at the single-cell level.
Source: Wiley
The relationship of FOXP3 expression and clinicopathological characteristics in adult T-cell leukemia/lymphoma
Source: Springer Science and Business Media LLC
CD4+CD25+FOXP3+ Regulatory T Cells Suppress Anti-Tumor Immune Responses in Patients with Colorectal Cancer
Source: PLOS
Regulatory T-cell function of adult T-cell leukemia/lymphoma cells.
Source: Wiley
Induction of FOXP3 expression in naive human CD4+FOXP3− T cells by T-cell receptor stimulation is transforming growth factor-β–dependent but does not confer a regulatory phenotype
Source: American Society of Hematology
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Source: American Association for the Advancement of Science (AAAS)
Epigenetic Control of the foxp3 Locus in Regulatory T Cells
Source: Public Library of Science (PLoS)
Role of Forkhead Box Protein 3 Expression in Invasive Breast Cancer
Source: American Society of Clinical Oncology (ASCO)
Local and systemic induction of CD4+CD25+ regulatory T-cell population by non-Hodgkin lymphoma.
Source: American Society of Hematology
Localisation pattern of Foxp3 + regulatory T cells is associated with clinical behaviour in gastric cancer
Source: Springer Science and Business Media LLC
Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells
Source: Oxford University Press (OUP)
In situ analysis of FOXP3+ regulatory T cells in human colorectal cancer
Source: Springer Science and Business Media LLC
TGF‐β‐induced Foxp3+ regulatory T cells rescue scurfy mice
Source: Wiley
Prevalence of Regulatory T Cells Is Increased in Peripheral Blood and Tumor Microenvironment of Patients with Pancreas or Breast Adenocarcinoma
Source: The American Association of Immunologists
Regulatory T cells, tumour immunity and immunotherapy
Source: Springer Science and Business Media LLC
Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma
Source: American Society of Hematology
Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells
Source: Rockefeller University Press
T regulatory cells in allergy: Novel concepts in the pathogenesis, prevention, and treatment of allergic diseases
Source: Elsevier BV
An essential role for Scurfin in CD4+CD25+ T regulatory cells.
Source: Springer Science and Business Media LLC
FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis
Source: American Association for Cancer Research (AACR)
Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.
Source: Springer Science and Business Media LLC
CD25+ FoxP3+ regulatory T cells in OSCC
Source: Wiley
The number of regulatory T cells in prostate cancer is associated with the androgen receptor and hypoxia-inducible factor (HIF)-2alpha but not HIF-1alpha.
Source: Wiley
Isoform-Specific Inhibition of RORα-Mediated Transcriptional Activation by Human FOXP3
Source: The American Association of Immunologists
Attack on the clones? Human FOXP3 detection by PCH101, 236A/E7, 206D, and 259D reveals 259D as the outlier with lower sensitivity.
Source: American Society of Hematology
Plasmacytoid Dendritic Cells Induce CD8+ Regulatory T Cells In Human Ovarian Carcinoma
Source: American Association for Cancer Research (AACR)
Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells.
Source: Wiley
Human Bladder Carcinoma is Dominated by T-Regulatory Cells and Th1 Inhibitory Cytokines
Source: Ovid Technologies (Wolters Kluwer Health)
Foxp3 expression in human cancer cells
Source: Springer Science and Business Media LLC
CD4+CD25high Regulatory Cells in Human Peripheral Blood
Source: The American Association of Immunologists
In Reply
Source: American Society of Clinical Oncology (ASCO)
Regulatory T cells.
Source: Elsevier BV
The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality.
Source: American Society of Hematology
Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma
Source: Springer Science and Business Media LLC
Possible origin of adult T-cell leukemia/lymphoma cells from human T lymphotropic virus type-1-infected regulatory T cells.
Source: Wiley
Short Report
Source: Wiley
Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells.
Source: American Association for Cancer Research (AACR)
Biologic predictors in follicular lymphoma: importance of markers of immune response.
Source: Informa UK Limited
Identification of a Regulatory T Cell Specific Cell Surface Molecule that Mediates Suppressive Signals and Induces Foxp3 Expression
Source: Public Library of Science (PLoS)
Cutting edge: Broad expression of the FoxP3 locus in epithelial cells: a caution against early interpretation of fatal inflammatory diseases following in vivo depletion of FoxP3-expressing cells.
Source: The American Association of Immunologists
Defense of the clone: antibody 259D effectively labels human FOXP3 in a variety of applications
Source: American Society of Hematology
Splice variants of human FOXP3 are functional inhibitors of human CD4+ T-cell activation
Source: Wiley
Rituximab-induced B cell depletion in autoimmune diseases: potential effects on T cells.
Source: Elsevier BV
Tumor infiltrating Foxp3+ regulatory T‐cells are associated with recurrence in pathologic stage I NSCLC patients
Source: Wiley
Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin’s lymphoma
Source: Ferrata Storti Foundation (Haematologica)
Foxp3 programs the development and function of CD4 + CD25 + regulatory T cells
Source: Springer Science and Business Media LLC
The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3.
Source: Springer Science and Business Media LLC

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.